A multi-institutional assessment of COVID-19-related risk in radiation oncology
Natalie Viscariello(University of Washington), Eric Ford(University of Washington), Christopher L. Hallemeier(Mayo Clinic in Arizona), L Fong de los Santos(Mayo Clinic in Florida), Suzanne B. Evans(Yale University), S. Parker(University of Southern California), Edward Y. Kim(University of British Columbia), L. Jordan(University of Washington), Brett Miller(Henry Ford Health System), Stephen Gardner(Henry Ford Health System), Deborah Schofield(AdventHealth Orlando)
Cited by 21
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters
|Nature Communications|2015|592
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Oesophageal cancer
|The Lancet|2024|265